Literature DB >> 10864547

Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study.

J T Salonen1, T P Tuomainen, K Kontula.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10864547      PMCID： PMC27415          DOI： 10.1136/bmj.320.7251.1706

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.

Authors:  T P Tuomainen; K Kontula; K Nyyssönen; T A Lakka; T Heliö; J T Salonen
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

Review 4.  Diabetes and haemochromatosis: current concepts, management and prevention.

Authors:  J M Yaouanq
Journal:  Diabete Metab       Date:  1995-12

5.  Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men.

Authors:  J T Salonen; K Nyyssönen; T P Tuomainen; P H Mäenpää; H Korpela; G A Kaplan; J Lynch; S P Helmrich; R Salonen
Journal:  BMJ       Date:  1995-10-28
  5 in total
  8 in total

1.  C282Y mutation and type 2 diabetes. Study was much too small for inferences to be drawn.

Authors:  D Curtis
Journal:  BMJ       Date:  2000-11-18

2.  Hereditary haemochromatosis: never seen a case?

Authors:  J Emery; P Rose
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

3.  The case for strengthening education and training for general practice.

Authors:  T van Zwanenberg; M Pringle; S Smail; M Baker; S Field
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

Review 4.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

5.  [Molecular genetic analysis and clinical aspects of patients with hereditary hemochromatosis].

Authors:  U Lange; J Teichmann; G Dischereit
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

Review 6.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

7.  Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy.

Authors:  I R Gunn; F K Maxwell; D Gaffney; A D McMahon; C J Packard
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

8.  Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.

Authors:  Gordon D McLaren; Christine E McLaren; Paul C Adams; James C Barton; David M Reboussin; Victor R Gordeuk; Ronald T Acton; Emily L Harris; Mark R Speechley; Phyliss Sholinsky; Fitzroy W Dawkins; Beverly M Snively; Thomas M Vogt; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.